Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Saba Capital Income & Opportunities Fund II | SABA | Aug 30, 2024 | 8.53 | +0.83 |
Sabine Royalty Trust Unit | SBR | Aug 30, 2024 | 64.24 | -0.96 |
Sable Offshore | SOC | Aug 30, 2024 | 16.84 | +2.18 |
Sabra Health Care REIT | SBRA | Aug 30, 2024 | 17.04 | +1.25 |
Sabre | SABR | Aug 30, 2024 | 3.05 | -0.65 |
Sachem Capital | SACH | Aug 30, 2024 | 2.45 | +0.82 |
Sachem Capital A Pref | SACH-A | Aug 30, 2024 | 21.19 | +0.26 |
Sacks Parente Golf | SPGC | Aug 30, 2024 | 2.87 | -1.37 |
Sadot Group | SDOT | Aug 30, 2024 | 0.39 | -4.73 |
Safe & Green Holdings | SGBX | Aug 30, 2024 | 1.27 | +12.39 |
Safe And Green Development | SGD | Aug 30, 2024 | 0.27 | 0.00 |
Safe Bulkers | SB | Aug 30, 2024 | 5.11 | +1.39 |
Safe Bulkers Pref C | SB-C | Aug 30, 2024 | 25.61 | -0.23 |
Safe Bulkers Pref D | SB-D | Aug 30, 2024 | 25.65 | -0.09 |
Safehold | SAFE | Aug 30, 2024 | 25.06 | +1.05 |
Safety Insurance Group | SAFT | Aug 30, 2024 | 88.55 | -0.29 |
Safety Shot | SHOT | Aug 30, 2024 | 0.92 | +3.76 |
Saga Communications A | SGA | Aug 30, 2024 | 14.72 | -2.06 |
Sage Therapeutics | SAGE | Aug 30, 2024 | 8.43 | +4.20 |
Sagimet Biosciences | SGMT | Aug 30, 2024 | 3.08 | 0.00 |
SAI.TECH Global | SAI | Aug 30, 2024 | 0.83 | -0.83 |
Saia | SAIA | Aug 30, 2024 | 375.83 | +0.42 |
Salarius Pharmaceuticals | SLRX | Aug 30, 2024 | 1.66 | -3.49 |
Salesforce | CRM | Aug 30, 2024 | 252.90 | -1.60 |
Sally Beauty | SBH | Aug 30, 2024 | 13.05 | +0.46 |
Samsara A | IOT | Aug 30, 2024 | 41.07 | +1.13 |
San Juan Basin Royalty Trust Unit | SJT | Aug 30, 2024 | 3.29 | -1.50 |
Sana Biotechnology | SANA | Aug 30, 2024 | 6.05 | -0.98 |
Sanara MedTech | SMTI | Aug 30, 2024 | 35.89 | +1.07 |
SandRidge Energy | SD | Aug 30, 2024 | 13.28 | -1.12 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.